Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business – GenomeWeb
The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.
The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.